Topic Listing for OraSure Technologies

Abbott Customer Information Abbott Distribution Agreement
Abbott Transition Ability Respond Changes Regulatory Requirements Adversely Affect Business
Ability Sell Products Adversely Affected Competition New Existing Ability Sell Products Affected Competition New Existing Diagnostic
Acceptance Adoption Oral Fluid Testing Not Continue Future Accounts Receivable
Accrued Expenses Acquired In-process Technology
Additional Offices Adjustments Changes Capitalization Etc
Administration Administration Award Plan
Advance Advertising Expenses
Advisers Board Directors Advisor
Agreement Agreement Provide Insurance
Alternate Dispute Resolution Adr Amendment
Amendment Award Plan Amendment Commercial Lease
Amendment Distribution Agreement Amendment Production Agreement
Amendment Restatement Award Plan Amendment Supply Distribution Agreement
Amendment Termination Amendments
Amendments Articles Incorporation Bylaws Change Annual Base Salaries
Annual Meeting Annual Meeting Attendance Stockholder Communications
Annual Meeting Stockholder Communications Annual Meetings
Annual Report Annual Revenues Reach Record Level Growth Over 2006
Annual Statement Business Anti-kickback Laws
Anti-takeover Provisions Certificate Incorporation Bylaws Stockholder Rights Plan Appointment
Approvals Article1 Miscellaneous
Audit Fees Audit-related Tax Other Availability Hiv-1 Antigen Screening Test
Award Awards
Background Background Information
Balance Sheets Become Involved Intellectual Property Infringement Disputes Costly Limit
Become Involved Intellectual Property Infringement Disputes Increase Costs Beneficial Ownership Reporting Compliance
Bethlehem Pennsylvania Board
Board Directors Board Directors Recommends Vote Against
Board Meetings Board Recommendation
Bonding Business Climate Trends Doug Michels
Business Strategy Business Update Doug Michels
Cash Equivalents Cash Flow Operations Liquidity Ron Spair
Caution Concerning Forward-looking Statements Certain Relationships Related Transactions
Certain Relationships Related Transactions Director Independence Certification
Chairman Board Changes Internal Control Over Financial Reporting
Chief Executive Officer Clinical Development Programs Oraquick Manufacturing
Code Comment
Committee Committees
Committees Board Common Stock
Common Stock Warrants Compared 2006
Compared 2007 Compared 2008
Comparison Cumulative Total Return Compensation
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Directors Compensation Reimbursement Expenses
Competition Competitive Economic Outlook
Compliance Certificate Composition
Conclusion Conclusion Doug Michels
Conference Call Confidentiality Non-use Information
Consent Independent Registered Public Accounting Firm Continuing Hiv Prevention Programs
Continuing Restriction Contractual Obligations Commercial Commitments
Controls Procedures Corporate Seal
Corporation Credit Facilities Contain Certain Financial Covenants Not Satisfied
Critical Accounting Policies Estimates Cryosurgical Product Extensions Doug Michels
Cryosurgical Systems Cryosurgical Systems Business
Cryosurgical Systems Doug Michels Cryosurgical Systems Market
Cryosurgical Systems Skin Lesion Removal Products Cryosurgical Systems Wart Removal Products
Current Financial Results Customers Resist Adoption Rapid Point-of-care Diagnostic Testing
Deadline Stockholder Proposals Deferral Elections
Definitions Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Dependent Strategic Partners Assist Developing Commercializing Some Diagnostic
Description Nonemployee Director Compensation Policy Description Nonemployee Director Compensation Policy Amended 2007
Designations Development High Throughput Oral Fluid Drugs Abuse Assays-
Direct Sales Hospitals Doug Michels Direct Selling Efforts Products Fail Business Expansion Plans
Director Independence Directors Executive Officers Corporate Governance
Directors Executive Officers Registrant Disability
Distribution Agreement Dividend Equivalents
Dividends Documents Incorporated Reference
Domestic Regulation Duration Plan Shares Subject
Earnings Loss Per Share Earnings Per Share
Economic Downturn Continue Indefinitely Intensify Adversely Affect Results Economic Downturn Terrorist Attacks Adversely Affect Business
Economic Downturn Terrorist Attacks National Disasters Adversely Affect Efforts Consolidate Restructure Adversely Affect Business
Election Officers Eligibility
Employee Stock Purchase Plan Employees
Employment Agreements Entry Material Agreement
Entry Material Definitive Agreement Environmental Regulation
Equity Compensation Plan Information Establishment Purpose
Estimates Estimates Judgments Relating Critical Accounting Policies Based Assumptions
Evaluation Disclosure Controls Procedures Exact Name Registrant Specified Charter
Exchange Act Execution Copy
Executive Compensation Executive Officers
Exercise Nonqualified Stock Options Exhibits
Expansion Advance Experience Fluctuations Financial Results Fail Meet Projections
Facsimile 914-524-6811 Failure Achieve Financial Strategic Objectives Material Adverse Impact
Failure Comply Fda Other Regulatory Requirements Require Suspend Failure Comply Fda Other Requirements Require Suspend Production
Failure Maintain Existing Distribution Channels Develop New Result Fair Market Value
Fair Value Financial Instruments Federal Income Tax Consequences
Financial Guidance Financial Guidance Ron Spair
Financial Overview- Doug Michels Financial Results Ron Spair
Financial Statements Exhibits Financial Statements Supplementary Data
Following Proxy Materials Available Review Online Foreign Corrupt Practices Act
Foreign Currency Translation Form 10-q
Forward-looking Statements Full 2007 Financial Guidance Ron Spair
Full 2008 Financial Guidance Ron Spair Full 2008 Outlook
Full Financial Results Ron Spair Full Results Ron Spair
Funding Bonus Pool Future Acquisitions Investments Disrupt Ongoing Business Distract Management
Future Sales Common Stock Existing Stockholders Executive Officers Future Sales Existing Stockholders Depress Market Price Common
Future Sales Existing Stockholders Executive Officers Directors Depress General
General Provisions Geographic Area Information
Geographic Information Government Regulation
Gross Margin Gross Margin Ron Spair
Guarantee Guidance Update
Held 2005 Held 2007
Held 2008 Held 2009
High Throughput Assays Doug Michels High Throughput Assays Substance Abuse Testing Business Doug
History Losses History Losses Not Able Achieve Sustained Profitability
History Losses Prior 2005 Hiv Otc Doug Michels
Hiv Over-the-counter Test Hiv-otc Doug Michels
Http Bnymellonmobularnet Bnymellon Osur Immediate Release
Immunoassay Tests Reagents Impairment Long-lived Assets
Important Information Inability Extend Shelf Life Oraquick Advance Hiv-1 Test
Inability Extend Shelf Life Oraquick Advance Test Adversely Inability Manufacture Products Accordance Applicable Specifications Performance Standards
Incentive Awards Income Taxes
Increases 2007 Full Revenue Guidance Increases Demand Products Require Expend Considerable Resources Meet
Increases Demand Products Require Spend Considerable Resources Meet Increases Full-year Earnings Guidance
Increases Guidance 2005 Net Income Increasing International Presence Affected Regulatory Cultural Other Restraints
Increasing International Presence Increase Risks Expose Business Regulatory Indemnification Insurance
Index Index Exhibits
Index Financial Statements Infectious Disease Doug Michels
Infectious Disease Testing Infectious Disease Testing Market
Insurance Information Insurance Risk Assessment
Insurance Risk Assessment Market Intellectual Property
Intercept Interest Income Expense
International International Markets
Internet Audio Broadcast Internet Telephone Voting Available Through 1159 Eastern Time
Introduction Doug Michels Inventories
Investor Confidence Share Value Adversely Impacted Independent Registered Involved Pending Become Future Intellectual Property Infringement Disputes
Iso Launch Newly Designed Website
Lawsuit Inverness Church Dwight Leases
Legal Proceedings License Agreement
License Product Development Licensing Product Development
Liquidity Capital Resources Litigation Settlement
Litigation Update Doug Michels Loan Security Agreement
Long-term Debt Lose Key Personnel Unable Attract Retain Qualified Necessary
Lost Destroyed Stock Certificates Management Incentive Plan
Management Stock Award Guidelines Managements Report Internal Control Over Financial Reporting
Manufacturing Operations Marked Signed Returned Proxy Card
Market Information Market Products Not Develop
Market Revenues Meeting Attendance
Meetings Miscellaneous
Name Name Person Filing Proxy Statement Other Registrant
Need Obtain Regulatory Approvals Increase Costs Adversely Affect Need Obtain Regulatory Approvals Respond Changes Requirements Adversely
Need Strategic Partners Assist Developing Commercializing Some Diagnostic Net Income Loss Ron Spair
Net Income Ron Spair Net Loss Per Common Share
Net Loss Ron Spair Net Sales Affected Third-party Reimbursement Policies Potential Cost
New Hiv Immunoassay Doug Michels Nomination Directors
Non-employee Director Non-gaap Financial Measures
Nonqualified Deferred Compensation Nonqualified Option
Notice Notice Annual Meeting Stockholders Held 2006
Notice Telephonic Attendance Unanimous Consent Obligations
Obligations Abbott Obligations Orasure
Operating Expenses Operating Expenses Ron Spair
Operations Update Doug Michels Option Exercises Stock Vested
Option Grants Last Options
Oraquick Oraquick Advance Hiv Manufacturing
Oraquick Discordant Results Doug Michels Oraquick Facetimes New Roman Size1 Platform
Oraquick Hcv Doug Michels Oraquick Hcv Test
Oraquick Hiv Oraquick Hiv Hospital Sales
Oraquick Hiv Manufacturing Oraquick Hiv Otc Test
Oraquick Hospital Sales Oraquick Manufacturing Challenges Doug Michels
Oraquick Platform Oraquick Rapid Test Platform
Oraquick Stability Oraquick Stability Doug Michels
Orasure Announces 2006 Financial Results Orasure Announces 2009 Financial Results
Orasure Announces Financial Results Orasure Announces Full 2007 Financial Results
Orasure Announces Full 2008 Financial Results Orasure Announces Record Financial Results
Orasure Announces Record Full Financial Results Orasure Facetimes New Roman Size1 Intercept Collection Devices
Orasure Increases 2006 Full Guidance Orasure Intercept Applications
Orasure Intercept Collection Devices Orasure Size1 Intercept Applications
Orasure Technologies Orasure Technologies Announces 2005 Results
Orasure Technologies Announces 2007 Results Orasure Technologies Announces 2008 Results
Orasure Technologies Announces Financial Results Orasure Technologies Announces Record 2007 Results
Orasure Technologies Announces Share Repurchase Program Orasure Technologies Appoints New Director
Orasure Technologies Defend Patent Infringement Lawsuit Orasure Technologies Inc
Orasure Technologies Provides Update Regarding Ordering Delivery
Organization Changes Doug Michels Organizational Changes
Organizational Changes Doug Michels Otc Cryosurgical Product Update Doug Michels
Otc Cryosurgical Systems Products Other Assets
Other Comprehensive Income Loss Other Events
Other Income Other Income Expense
Other Information Other Stock-based Combination Awards
Outlook Outlook 2007 Doug Michels
Over 400 Testing Sites 250000 Tests Overview
Part Part Financial Information
Part Other Information Participant
Patent Infringement Litigation Patents Product Rights
Patents Proprietary Information Payment Terms Minimum Purchase Commitments
Payments Bonus Pool Pending Litigation
Pension Benefits Percent Shareholder
Performance Award Performance Awards
Performance Cycle Performance Goal
Performance Graph Performance Products Affect Revenues Stock Price
Performance Products Affect Revenues Stock Price Reputation Phosphor Agreements
Plan Please Date Sign Return Proxy Card Promptly
Portfolio Investments Subject Volatility Uncertainty Financial Markets Other Power Attorney
Powers Board Pre-clinical Trials Human Subjects
Preemptive Rights Denied Prepared Remarks Douglas Michels Ronald Spair
Presentation Business Stockholders Meetings President
Presiding Officials Prestige Brands
Prestige Brands Dispute Prestige Brands Found Breached Non-compete Provision
Prices Principal Accountant Fees Services
Principal Office Principal Stockholders
Product Commercialization Product Specifications
Product Warranties Products
Products Development Professional Products
Program Update Doug Michels Properties
Property Acquisition Property Equipment
Prototype Rapid Hcv Antibody Test Aacc Annual Meeting Proxies
Proxy Solicited Behalf Board Directors Proxy Statement
Purchase Commitments Purpose
Pursuant Requirements Securities Exchange Act 1934 Registrant Duly Pursuant Requirements Securities Exchange Act 1934 Report Been
Qed Saliva Alcohol Test Qed Size1 Saliva Alcohol Test
Qualification Quality Assurance
Quantitative Qualitative Disclosures Market Risk Quarterly Period 2006
Quarterly Period 2008 Quarterly Revenues Increase Over 2006
Quorum Adjournment Rapid Hiv-1 Antibody Test Directly Hospitals
Recall Complaints Recent Accounting Pronouncements
Recent Developments Recitals
Record Quarterly Revenues Led Oraquick Advance Sales Registrants Telephone Number Including Area Code
Registrants Telephone Number Including Area Code 610-882-1820 Regulation
Regulation Disclosure Regulatory Risks
Report Audit Committee Report Executive Compensation
Report Independent Registered Public Accounting Firm Reported Financial Results Adversely Affected Changes Accounting Principles
Reporting Person Reporting Responsibility
Representations Additional Warranties Indemnification Request Paper Copy Proxy Materials Reference Digit Control
Require Future Additional Capital Require Future Additional Capital Fund Operations
Research Development Research Development Commercialization Efforts Not Succeed Competitors Develop
Response Restricted Award
Restricted Awards Restricted Unit
Restriction Results Include 182 Tax Benefit
Results Operations Results Operations Financial Condition
Results Ron Spair Resumption Full-scale Oraquick Production
Retirement Revenue Recognition
Revenue Segment Revenues Affected Third-party Reimbursement Policies Potential Cost Constraints
Revenues Ron Spair Risk Factors
Risks Relating Collaborators Risks Relating Common Stock
Risks Relating Industry Business Strategy Risks Relating Intellectual Property
Risks Relating Product Marketing Sales Risks Relating Products Marketing Sales
Ronald Spair Sales Cycles Lengthy Depend Public Funding Cause Variability
Sales Marketing Sales Potential Oraquick Advance Affected Ability Obtain Certain
Sales Potential Oraquick Affected Ability Obtain Certain Licenses Sales Potential Oraquick Products Affected Ability Obtain Certain
Sar Sarbanes-oxley Act 2002
Schering-plough Patent Infringement Litigation Scholle Corporation
Secretary Secretary Assistant Secretaries
Securities Exchange Act 1934 Securities Registered Pursuant Act
Security Ownership Certain Beneficial Owners Management Self-funding Management Incentive Plan
Session Regarding Business Update Settle Patent Infringement Litigation
Share Repurchase Program Share Repurchases Retirements
Shareholder Approval Shares Stock
Shares Subject Award Plan Signature Page Follows
Signatures Significant Customer Concentration
Significant Milestones Achieved Clinical Development Programs Significant Products Customers
Sole Supply Sources Critical Components Products Adversely Affect Sole Supply Sources Party Suppliers Critical Components Products
Special Meeting Special Meetings
Specific Duties Employee Executive Vice President Chief Science Specific Duties Employee Executive Vice President Operations
Specific Duties Employee Senior Vice President Finance Controller Ssl Distribution Agreement
Stock Appreciation Rights Stock Award Plan
Stock Awards Stock Guidelines
Stock Price Continue Volatile Stock Price Performance Graph
Stock Repurchase Plan Stock Transfers
Stock-based Compensation Stockholder Proposal
Stockholders Equity Strategy Update
Subject Numerous Government Regulations Addition Fda Requirements Increase Sublicense Agreement
Submission Matters Vote Security Holders Subsidiary
Substance Abuse Doug Michels Substance Abuse Testing
Substance Abuse Testing Market Success Depends Ability Protect Proprietary Technology
Sued Product Liabilities Injuries Resulting Products Suffer Monetary Damages Incur Substantial Costs Prevented Using
Summary Award Plan Amended Summary Contractual Obligations
Summary Doug Michels Supplemental Cash Flow Information
Supply Distribution Agreement Supply Manufacturing
Supporting Statement Table
Table Contents Term Termination
Termination Material Definitive Agreement Termination Royalty Agreement
Termination Transition Agreement Territory
Terrorist Attacks National Disasters Adversely Affect Business Title Class
Transactions Related Persons Transfer Price Adjustments
Treasurer Assistant Treasurers Tuesday 2005
Tuesday 2006 Tuesday 2009
Unavailability Certain Products Distributed Party Adversely Affect Sales Unexpected Increases Demand Products Require Spend Considerable Resources
United States Updated Financial Guidance
Uplink Upt Development
Utilization Deferred Tax Assets Limited Dependent Future Taxable Vested
Via Federal Express Vice Presidents
Vote Internet Voting
Voting Procedures Voting Securities
Warranties Western Blot Hiv-1 Confirmatory Test
Year-end Option Values 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki